• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌肝部分切除术后肝内复发的预测因素

Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy.

作者信息

Arii S, Tanaka J, Yamazoe Y, Minematsu S, Morino T, Fujita K, Maetani S, Tobe T

机构信息

First Department of Surgery, Kyoto University Faculty of Medicine, Japan.

出版信息

Cancer. 1992 Feb 15;69(4):913-9. doi: 10.1002/1097-0142(19920215)69:4<913::aid-cncr2820690413>3.0.co;2-t.

DOI:10.1002/1097-0142(19920215)69:4<913::aid-cncr2820690413>3.0.co;2-t
PMID:1310434
Abstract

To establish useful predictors of the intrahepatic recurrence of hepatocellular carcinoma (HCC) after partial hepatectomy, retrospective analyses of clinical and pathologic factors were done in 112 of 206 patients treated by partial hepatectomy. The absence or presence of intrahepatic recurrence was confirmed by a follow-up study. Cancer-free survival rates after 1, 2, 3, and 5 years were 54.8%, 36.7%, 32.5%, and 25.6%, respectively. The significant factors affecting recurrence were tumor size, number of tumors, cancer cell infiltration of the fibrous capsule of the tumor, portal involvement, and stage of the tumor, but the grade of anaplasia according to Edmondson-Steiner's classification and the severity of associated liver cirrhosis did not show a correlation with the incidence of recurrence. According to Akaike's Information Criteria (AIC), tumor number is useful for predicting early prognosis, and capsular infiltration is a good indicator of long-term survival. However, portal involvement gives much prognostic information throughout the entire postoperative period.

摘要

为了建立肝细胞癌(HCC)肝部分切除术后肝内复发的有效预测指标,我们对206例行肝部分切除术患者中的112例进行了临床和病理因素的回顾性分析。通过随访研究确认肝内复发的有无。1年、2年、3年和5年的无癌生存率分别为54.8%、36.7%、32.5%和25.6%。影响复发的显著因素包括肿瘤大小、肿瘤数量、肿瘤纤维包膜的癌细胞浸润、门静脉受累情况和肿瘤分期,但根据Edmondson-Steiner分类法的间变程度以及相关肝硬化的严重程度与复发率无相关性。根据赤池信息准则(AIC),肿瘤数量有助于预测早期预后,包膜浸润是长期生存的良好指标。然而,门静脉受累在整个术后期间提供了很多预后信息。

相似文献

1
Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy.肝细胞癌肝部分切除术后肝内复发的预测因素
Cancer. 1992 Feb 15;69(4):913-9. doi: 10.1002/1097-0142(19920215)69:4<913::aid-cncr2820690413>3.0.co;2-t.
2
Prognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer?高分化小肝细胞癌的预后——高分化肝细胞癌在临床上属于早期癌症吗?
Hepatogastroenterology. 1995 Nov-Dec;42(6):923-30.
3
[Prognostic factors influencing postoperative survival in patients with </= 3 cm small hepatocellular carcinoma].[影响≤3cm小肝细胞癌患者术后生存的预后因素]
Zhonghua Wai Ke Za Zhi. 2005 May 1;43(9):579-83.
4
Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.肝细胞癌肝切除术后肝内复发患者的预后:一项回顾性研究。
Eur J Surg Oncol. 2009 Feb;35(2):174-9. doi: 10.1016/j.ejso.2008.01.027. Epub 2008 Mar 5.
5
Factors affecting postoperative prognosis in the solitary-nodule type of hepatocellular carcinoma: experience of 132 cases in our institute.
Hiroshima J Med Sci. 1998 Sep;47(3):99-104.
6
Edmondson grade predicts survival of patients with primary clear cell carcinoma of liver after curative resection: A retrospective study with long-term follow-up.埃德蒙森分级可预测肝原发性透明细胞癌患者根治性切除术后的生存率:一项长期随访的回顾性研究
Asia Pac J Clin Oncol. 2017 Oct;13(5):e312-e320. doi: 10.1111/ajco.12494. Epub 2016 Apr 21.
7
Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.肝细胞癌患者的微血管侵犯及其可预测的临床病理因素。
Ann Surg Oncol. 2008 May;15(5):1375-82. doi: 10.1245/s10434-008-9846-9. Epub 2008 Mar 7.
8
Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.利用CLIP评分预测肝细胞癌患者切除术后的复发及预后
World J Gastroenterol. 2002 Apr;8(2):237-42. doi: 10.3748/wjg.v8.i2.237.
9
Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.埃德蒙森-施泰纳分级:无微血管侵犯的肝细胞癌复发和生存的关键预测指标。
Pathol Res Pract. 2017 Jul;213(7):824-830. doi: 10.1016/j.prp.2017.03.002. Epub 2017 Mar 8.
10
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.Akt磷酸化是肝细胞癌早期疾病复发和预后不良的一个危险因素。
Cancer. 2005 Jan 15;103(2):307-12. doi: 10.1002/cncr.20774.

引用本文的文献

1
From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring.从预测到预防:机器学习引发肝细胞癌复发监测革命。
World J Gastroenterol. 2024 Feb 21;30(7):631-635. doi: 10.3748/wjg.v30.i7.631.
2
Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.使用钆塞酸增强 MRI 对肝细胞癌微血管侵犯进行多参数评估。
Abdom Radiol (NY). 2024 May;49(5):1467-1478. doi: 10.1007/s00261-023-04179-3. Epub 2024 Feb 15.
3
Current status and prospect of treatments for recurrent hepatocellular carcinoma.
复发性肝细胞癌治疗的现状与展望
World J Hepatol. 2023 Feb 27;15(2):129-150. doi: 10.4254/wjh.v15.i2.129.
4
Transarterial chemoembolization versus surgical resection for giant hepatocellular carcinoma under the different status of capsule: a retrospective study.不同包膜状态下巨大肝细胞癌经动脉化疗栓塞术与手术切除的对比:一项回顾性研究
Transl Cancer Res. 2022 Dec;11(12):4359-4372. doi: 10.21037/tcr-22-2473.
5
Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatment.改善肝癌伴门静脉癌栓患者肝切除术后的结局:治疗演进时代的探索。
World J Surg Oncol. 2021 Oct 26;19(1):313. doi: 10.1186/s12957-021-02425-w.
6
Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma.自然杀伤细胞活性是肝癌根治性治疗后复发风险的一个危险因素。
BMC Gastroenterol. 2021 Jun 12;21(1):258. doi: 10.1186/s12876-021-01833-2.
7
Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.中性粒细胞与淋巴细胞比值升高和肝内胆管细胞癌为主型与合并肝细胞癌-胆管细胞癌患者肝切除术后不良结局相关。
PLoS One. 2020 Dec 11;15(12):e0240791. doi: 10.1371/journal.pone.0240791. eCollection 2020.
8
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma.肝细胞癌完全治愈后复发模式和预测因素的时间变化。
Gut Liver. 2021 May 15;15(3):420-429. doi: 10.5009/gnl20101.
9
Correlation of KAI1, CD133 and vasculogenic mimicry with the prediction of metastasis and prognosis in hepatocellular carcinoma.KAI1、CD133与血管生成拟态在肝细胞癌转移及预后预测中的相关性
Int J Clin Exp Pathol. 2018 Jul 1;11(7):3638-3646. eCollection 2018.
10
Utility and Limitation of Preoperative Neutrophil Lymphocyte Ratio as a Prognostic Factor in Hepatocellular Carcinoma.术前中性粒细胞淋巴细胞比值作为肝细胞癌预后因素的效用与局限性
Yonago Acta Med. 2018 Dec 27;61(4):197-203. doi: 10.33160/yam.2018.12.002. eCollection 2018 Dec.